American foulbrood

Bee Vaccine Pioneer Dalan Secures $4.5M to Fuel Global Expansion and Product Development

Retrieved on: 
Tuesday, June 27, 2023
Veterinary, Environment, Venture Capital, Professional Services, Food, Beverage, Health, Retail, Agriculture, Natural Resources, Diamond, Version One Ventures, HSKA, American foulbrood, Farmer, General partnership, Plant, Biodiversity, USDA, Pollination, Dalan, Biomass, Pharmaceutical industry, David Heska Wanbli Weiden

The additional funding will enable Dalan to expedite its product pipeline and expand its operations beyond the United States.

Key Points: 
  • The additional funding will enable Dalan to expedite its product pipeline and expand its operations beyond the United States.
  • With the largest honeybee sector residing in Europe, boasting 20 million hives compared to the US's 2.67 million, the global need for sustainable solutions in bee health is evident.
  • Dalan is committed to making its groundbreaking technology available where it is most needed, as swiftly as possible.
  • "Their pioneering work in developing the world's first honeybee vaccine has the potential to transform the agricultural sector and secure the global food supply."

Dalan Animal Health Ships First Honey Bee Vaccine to Tauzer Apiaries, Potentially Protecting 25 Million Bees.

Retrieved on: 
Tuesday, May 23, 2023
Environment, Infectious Diseases, Environmental Issues, Environmental Health, Sustainability, Biotechnology, Health, Agriculture, Natural Resources, Honey, Diamond, Infection, HSKA, American foulbrood, Bee, U.S. Department of Defense Strategy for Operating in Cyberspace, Paenibacillus larvae, Food, Beekeeper, U.S. Department of Agriculture Cotton Annex, Climate change, USDA, Clarence J. Tauzer, Incineration, Paenibacillus, Pollination, Bacteria, Dalan, Disease, David Heska Wanbli Weiden

Dalan Animal Health, Inc. (“Dalan”), the biotech company pioneering insect health with the world’s first honey bee vaccine, is proud to announce its first product shipment to a commercial beekeeper.

Key Points: 
  • Dalan Animal Health, Inc. (“Dalan”), the biotech company pioneering insect health with the world’s first honey bee vaccine, is proud to announce its first product shipment to a commercial beekeeper.
  • The shipment is for Trevor Tauzer of Tauzer Apiaries in California and contains 500 doses, potentially protecting 25 million bees at an average of 50,000 bees per hive.
  • Tauzer, also a board member of the California State Beekeepers Association , said, “We are excited about the arrival of Dalan's honey bee vaccine.
  • The honey bee vaccine, manufactured by Diamond Animal Health (Des Moines, IA), a wholly-owned subsidiary of Heska (NASDAQ: HSKA), will initially be distributed on a limited basis to commercial beekeepers and queen producers.

First-in-Class Honeybee Vaccine Receives Conditional License from the USDA Center for Veterinary Biologics

Retrieved on: 
Wednesday, January 4, 2023
Environment, Technology, Consumer, Other Health, Specialty, Retail, Fund Raising, Foundation, Science, Veterinary, Biotechnology, Philanthropy, Food Tech, Other Natural Resources, Health, Other Consumer, Other Technology, Agriculture, Natural Resources, Other Science, Pets, Research, Diamond, U.S. Department of Defense Strategy for Operating in Cyberspace, American foulbrood, Agriculture, Food, Infection, Element, Pollination, Foster & Kleiser, Vaccination, U.S. Department of Agriculture Cotton Annex, Bee, Paenibacillus larvae, USDA, Health, Incineration, HSKA

One-third of the global food supply relies on pollination, and healthy commercial hives are essential to secure high crop yields.

Key Points: 
  • One-third of the global food supply relies on pollination, and healthy commercial hives are essential to secure high crop yields.
  • Global population growth and changing climates will increase the importance of honeybee pollination to secure our food supply.
  • The USDA has issued the conditional license in the first instance for two years.
  • Dalan will distribute the vaccine on a limited basis to commercial beekeepers and anticipates having the vaccine available for purchase in the United States in 2023.

Study Reveals First-Ever Insect Vaccine for Honeybees is Safe and Effective

Retrieved on: 
Tuesday, October 18, 2022
Philanthropy, Other Natural Resources, Sustainability, Public Policy, Government, Agriculture, Natural Resources, Other Science, Research, Fund Raising, Foundation, Science, Veterinary, Environmental Policy, Animal Welfare, Environmental Issues, Agritech, Environmental Health, General Health, Pharmaceutical, University, Education, Infectious Diseases, Other Technology, Environment, Food, Beverage, Biotechnology, Technology, Retail, Health, Other Policy Issues, American foulbrood, University of Graz, Disease, Agriculture, Vaccine, Immunity, Health, Research, Disease resistance, Partnership, Technology, Invertebrate, University, Food industry, Industry, CEO, Forestry, Egg, Safety, University of Georgia College of Veterinary Medicine, Survival, Veterinary Research, Pollination, USDA, Innovation Hub, Center for International Forestry Research, Pharmaceutical industry

However, honeybees are plagued by diseases worldwide, with previously no safe and sustainable solution for disease prevention.

Key Points: 
  • However, honeybees are plagued by diseases worldwide, with previously no safe and sustainable solution for disease prevention.
  • "Honeybees are such an important link in our food supply chain, But the industry is at a breaking point.
  • The vaccine protects honeybees from American Foulbrood through transgenerational immune priming, where the maternal organism can transfer immunity to a pathogen onto the next generation.
  • Large-scale field efficacy pilot trials are underway as Dalan Animal Health seeks to bring to market the first-ever USDA-CVB-licensed insect vaccine for honeybees.

Dalan Animal Health Closes $3.55 Million Financing Round for Launch of the World’s First Honeybee Vaccine

Retrieved on: 
Tuesday, September 27, 2022
Finance, Pharmaceutical, General Health, Professional Services, Other Natural Resources, Environment, Environmental Health, Venture Capital, Agriculture, Natural Resources, Biotechnology, Science, Veterinary, Other Science, Research, Health, Reproduction, Invertebrate, Health, Agriculture, Genetically modified bacteria, Vaccination, Growth, Version One Ventures, U.S. Department of Defense Strategy for Operating in Cyberspace, Technology, Vaccine, Louisiana State University Agricultural Center, Solution, Seed, Nut, Veterinary biologic, Ecosystem, Food, Biomass, Organic, Plant, Disease, Soil, Aquaculture, American foulbrood

Dalan Animal Health, Inc., a biotech company pioneering insect health and immunology, today announced the close of a $3.55 million seed financing round led by At One Ventures and Veterinary Angel Network for Entrepreneurs (VANE).

Key Points: 
  • Dalan Animal Health, Inc., a biotech company pioneering insect health and immunology, today announced the close of a $3.55 million seed financing round led by At One Ventures and Veterinary Angel Network for Entrepreneurs (VANE).
  • This is the second seed round of funding and the first including institutional investors, bringing the total raise to $5.5 million.
  • The vaccine that Dalan is developing is non-GMO, has no harmful additives, and is suitable for use in organic agriculture.
  • Dalan is not only a bee vaccine company but is pioneering sustainable solutions in insect health to save our planet.

Biotech Company Dalan Animal Health Relocates to Athens, Georgia

Retrieved on: 
Wednesday, June 1, 2022
Faculty, Economic development, Innovation Hub, Georgia Department of Economic Development, Environmental science, Agriculture, Company, University of Georgia, Veterinary medicine, Campuses of the University of Georgia, University of Georgia College of Agricultural and Environmental Sciences, University of Georgia College of Veterinary Medicine, CEO, UGA, University, Growth, Student, American foulbrood, Farm, Health, Grasshopper, Quality of life, College, Management, Innovation district, ATHENS

ATHENS, Ga., June 1, 2022 /PRNewswire/ -- Dalan Animal Health, Inc., a biotech company focused on insect health, announced today that it will relocate its headquarters to Athens, Georgia. The company is anticipated to create 20 new jobs over the next five years.

Key Points: 
  • ATHENS, Ga., June 1, 2022 /PRNewswire/ -- Dalan Animal Health , Inc., a biotech company focused on insect health, announced today that it will relocate its headquarters to Athens, Georgia.
  • Dalan Animal Health ( www.dalan.com ) seeks to prevent diseases that affect beneficial insect populations to increase the profitability and yield of pollinated crop farms worldwide.
  • "Athens is the ideal location to build an innovative biotechnology company focused on sustainable agriculture," explains Dr. Annette Kleiser, CEO of Dalan Animal Health.
  • The Athens-Clarke County Economic Development Department worked with the Georgia Department of Economic Development and University of Georgia Economic Development and Innovation Gateway on the company's relocation.